- Tytuł:
- Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study
- Autorzy:
- Źródło:
- In Digestive and Liver Disease January 2024
Czasopismo naukowe